MINDCURE Appoints Dr. John Brownstein, the Chief Innovation Officer at Boston Children’s Hospital, as Company… May 19, 2021
Mountain Valley MD CEO Dennis Hancock Talks Ivectosol Results, The Politicization Of Ivermectin, And More May 19, 2021
More Than 80% Of Americans Report One Or More Symptoms Of Depression, And Many Have Turned To Substances To Cope With… May 18, 2021
Cybin Granted IRB Approval for Phase II Clinical Trials of its Sublingual Psilocybin Formulation for the Treatment of… May 18, 2021
